ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Home - FI zu Bisoprolol NOBEL
Fachinformation zu Bisoprolol NOBEL:NOBEL Pharma Schweiz AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
C07AB07 - BisoprololATC-DDD Version 2016. Source: WHO
C - Cardiovascular System
 
C07 - Beta Blocking Agents
 
C07A - Beta Blocking Agents

All plain beta blocking agents are classified in this group. Combination packages containing two different products (e.g. sotalol tablets and aspirin tablets in a combination package) are also classified in this group.
Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.
Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.
Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.

The DDDs are based on the treatment of mild-moderate hypertension.
The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol.

C07AB - Beta Blocking Agents, Selective

All plain selective beta blocking agents are classified in this group.
The s-enantiomer and the racemate of atenolol are classified at separate 5th levels.

Different DDDs have been assigned for the two stereoisomeric forms of atenolol due to different potency.

C07AB07 - Bisoprolol
StärkeAdm.RouteNote
 O 
 
Arzneimittel A-Z | ATC-Browser | Neuregistrierungen
2021 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home